Loading...

Loading...

 FDA Clears Pfizer-BioNTech Omicron Adapted Vaccine for All Ages
By Anmol Motwani - Mon, 09/11/2023 - 11:10
Pfizer and BioNTech gain FDA approval for a tailored Omicron COVID-19 vaccine, offering enhanced during the upcoming fall and winter seasons.
https://mexicobusiness.news/tag/omicron
More Health
WHO Monitors EG.5, CDC Tracks BA.2.86 Variant
By Anmol Motwani - Wed, 08/23/2023 - 16:11
The WHO maintains vigilance over the transmissible EG.5 variant, while the CDC uncovers BA.2.86 lineage mutations, prompting global health precautions
WHO Urges Data Sharing as EG.5 Variant Spreads
By Anmol Motwani - Fri, 08/11/2023 - 17:25
As the EG.5 variant gains ground in multiple countries, the WHO underscores the importance of data to facilitate research and drug trials.
Raising Awareness on Food Labels: The Week in Health
By Antonio Gozain - Thu, 11/10/2022 - 10:00
The Partnership for Food Security protested in front of SCJN to defend a much-discussed law that makes labels on food packaging mandatory.
Mexico to Update Epidemiological Map System
By Alfonso Núñez - Tue, 01/18/2022 - 10:41
The current strategy to determine a state’s safety status is outdated, say officials, and will be adapted to reflect the impact of Omicron.
Teachers’ COVID-19 Vaccine Booster Shots Delayed
By Alfonso Núñez - Fri, 01/07/2022 - 16:12
A shipment of Moderna vaccines has been unable to leave the US, delaying Mexico’s booster vaccination campaign.
COVID-19 Variants Threaten the New Year
By Miriam Bello - Thu, 01/06/2022 - 13:26
This week several countries reported record numbers of COVID-19 infections. Cases are also rapidly climbing in Mexico.
Mexico to Allow Entry to Cruise Ships With COVID-19 Patients
By Alfonso Núñez - Tue, 12/28/2021 - 12:20
After turning away cruise ships with members on board testing positive for COVID-19, the country has announced it will allow them to dock.
Mexico Still Without an Omicron Spike
By Alfonso Núñez - Mon, 12/27/2021 - 14:14
While Omicron cases appear to be limited in Mexico, this could be due to limited testing efforts.